The prognostic role of the immune status of TILs in triple negative and HER2-positive subtypes has been extensively studied [33], while in luminal breast cancers (LBC) it remains more elusive [34]. The gene discussed is ERBB2; the disease is CDH1-related diffuse gastric and lobular breast cancer syndrome.